[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"countryName\":\"Greenland\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":103},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,49,76],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":29,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":37,"lastUpdatePostDateStruct":38,"startDateStruct":41,"completionDateStruct":43,"leadSponsor":45,"locationsCount":48},"100651700","retrieval-of-transurethrally-resected-intact-en-bloc-vesical-tumors-using-a-retrieval-device-for-bladder-tumors-100651700",false,"NCT07762820","REtrieval of Transurethrally Resected Intact En-bloc Vesical Tumors Using a Retrieval Device for Bladder Tumors","REtrieval of Transurethrally Resected Intact En-bloc Vesical Tumors Using a Retrieval Device for Bladder Tumors - A Prospective Multicenter Feasibility Study","RETRIEVE-BT","Inclusion Criteria:\n\n* Age ≥18 years at the time of enrollment\n* Suspected primary non-muscle invasive bladder cancer (NMIBC; stage pTa or pT1) based on cystoscopic assessment, with no radiological or clinical evidence of muscle-invasive disease\n* Solitary or multiple bladder tumors with an estimated largest diameter of ≤50 mm based on flexible or rigid cystoscopic assessment (or cross-sectional imaging if available)\n* Clinical indication for elective transurethral resection of the bladder tumor, planned to be performed as en-bloc resection\n* Written informed consent obtained prior to any study-related procedure\n* Ability to understand the study procedures and willingness to comply with study requirements\n\nExclusion Criteria:\n\n* Known or clinically suspected muscle-invasive bladder cancer (MIBC; cT2 or higher) based on cystoscopy or imaging\n* Recurrent bladder tumor (prior history of bladder tumor resection within the past 24 months)\n* Active untreated urinary tract infection at the time of surgery (requiring postponement and re-evaluation)\n* Uncorrectable coagulopathy or anticoagulation that cannot be safely paused perioperatively\n* Severe urethral stricture precluding standard resectoscope passage\n* Inability to provide written informed consent (e.g., due to cognitive impairment or language barrier without translation support)","ALL","18 Years",{"count":20,"type":21},75,"ESTIMATED","INTERVENTIONAL",[24],"NA","Bladder cancer is the most common malignancy of the urinary tract, and approximately 75% of cases are non-muscle invasive (NMIBC) at diagnosis. The standard treatment is transurethral resection of the bladder tumor (TURBT). En bloc resection (EBR-T), in which the tumor is removed in one intact piece rather than fragmented, offers superior pathological specimen quality and may reduce the need for repeat resections. However, extracting the intact specimen from the bladder through the urethra remains a critical technical challenge, particularly for larger tumors.\n\nCURTIS (Urotech GmbH) is a CE-marked retrieval device consisting of a hydrophilic-coated bag that can be opened and closed via a handpiece, enabling controlled capture and safe transurethral extraction of the resected tumor specimen.\n\nThis study aims to evaluate the technical feasibility of CURTIS-assisted intact specimen retrieval following en bloc transurethral resection of primary NMIBC. The central question the study seeks to answer is: in what proportion of cases can CURTIS successfully retrieve an intact en bloc resected bladder tumor, and what is the maximum tumor size for which intact retrieval remains feasible?",[27,28],"Bladder Cancer","Bladder Cancer TNM Staging Primary Tumor (T) T1",[30,31,32,33,34,35],"bladder cancer","urothelial cell cancer","en-bloc","retrieval","transurethral resection of bladder tumor","TUR-BT","NOT_YET_RECRUITING","2026-08-13",{"date":39,"type":40},"2026-08-17","ACTUAL",{"date":42,"type":21},"2026-09-01",{"date":44,"type":21},"2027-03-31",{"name":46,"class":47},"Ludwig-Maximilians - University of Munich","OTHER",9,{"id":50,"slug":51,"hasResults":11,"nctId":52,"briefTitle":53,"officialTitle":54,"acronym":55,"eligibilityCriteria":56,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":57,"targetDuration":4,"studyType":22,"phases":59,"briefSummary":60,"conditions":61,"keywords":4,"overallStatus":65,"whyStopped":4,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":75},"100591711","increasing-physical-activity-among-medical-inpatients-by-digital-nudging-of-patients-and-staff-100591711","NCT06983977","Increasing Physical Activity Among Medical Inpatients by Digital Nudging of Patients and Staff","Increasing Physical Activity Among Medical Inpatients by Digital Nudging of Patients and Staff - A Cluster Randomised Multicentre Study","IPAMINA","Inclusion Criteria:\n\n* Admitted to one of the participating wards\n* Has understood and signed informed consent\n* Reads and understands Danish, Faroese, Greenlandic or English\n\nExclusion Criteria:\n\n* Has an expected hospitalisation less than 24 hours after potential recruitment\n* Is not able to give informed consent to participate in the study\n* Has allergy towards band aid\n* Not able to (shortly) stand in an upright position even with maximal assistance\n* There are contraindications for the patient to mobilise or be physically active due to unstabilized acute medical conditions, including, but not limited to, acute aortic dissection, -myocardial infarction, -pulmonary embolism, -sepsis.\n* There are ethical concerns regarding the patients' participation in the study, including, but not limited to, the patient being:\n\n  * In the terminal phase of life\n  * In a crisis state regarding their disease\u002Fsituation and deemed unfit for participation\n\nTo ensure medically responsible inclusion of patients, the project personnel will consult and confer with the treatment responsible medical doctor, or their delegate, before including a potential participant for the trial.",{"count":58,"type":21},400,[24],"Sedentary behaviour among medical inpatients is strongly associated with hospital-associated functional decline and poses a severe threat to patients' functional capacity and independency. High human and socioeconomic costs underline the urgency to find solutions to this world-wide problem.\n\nObjective: This multicentre study, including a total of 400 patients from Copenhagen, Aalborg, Tórshavn, and Nuuk, will assess the effect of a digital intervention that aims to reduce sedentary behaviour and increase physical activity in medical inpatients.\n\nIntervention: Digital feedback and nudging regarding the patients' physical activity levels to patients and healthcare staff Design: Stepped-wedge cluster randomised multicentre trial Primary outcome: Daily average time of patients' physical activity (minutes).",[62,63,64],"Physical Activity","Inpatients","Digital Health","RECRUITING","2025-05-21",{"date":68,"type":40},"2025-05-25",{"date":70,"type":40},"2025-05-19",{"date":72,"type":21},"2027-12",{"name":74,"class":47},"Bispebjerg Hospital",4,{"id":77,"slug":78,"hasResults":11,"nctId":79,"briefTitle":80,"officialTitle":80,"acronym":4,"eligibilityCriteria":81,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":82,"targetDuration":4,"studyType":22,"phases":84,"briefSummary":85,"conditions":86,"keywords":4,"overallStatus":65,"whyStopped":4,"lastUpdateSubmitDate":93,"lastUpdatePostDateStruct":94,"startDateStruct":96,"completionDateStruct":98,"leadSponsor":100,"locationsCount":102},"100536407","phenotypic-and-genotypic-characterization-of-patients-with-dysmetabolism-in-greenland-100536407","NCT06264427","Phenotypic and Genotypic Characterization of Patients With Dysmetabolism in Greenland","Inclusion Criteria:\n\n* Type 2 diabetes and\u002For morbid obesity (BMI \\>40)\n* Over 18 years old\n\nExclusion Criteria:\n\n* Does not speak either English, Danish or Greenlandic",{"count":83,"type":21},1000,[24],"The goal of this clinical trial is to perform a detailed description of the feno- and genotype of people living with type 2 diabetes and severe obesity who are linked to care at Steno Diabetes Center Greenland.\n\nThe main questions it aims to answer are:\n\n* Are monogenetic diabetes variants associated with the same risk of developing late diabetic complications as other types of diabetes?\n* Can genotyping and thereby personalized medicine be implemented in Greenland, and can personalized medicine lead to improved treatment?\n* What is the prevalence of sleep apnea among high-risk individuals in Greenland?\n* Is it possible to develop and implement a simple algorithm for the identification of sleep apnea in Greenland that can ensure treatment of severe sleep apnea?\n\nParticipants will:\n\n* Answer WHO-5 and FOSQ-10 questionnaires regarding quality of life and functional outcomes of sleepiness\n* Perform VAGUS examinations for Cardiovasculare Autonomic Neuropathy\n* Clinical examination of height, weight, circumference of hip, waist and neck, Friedman tonsil and tongue score, nasal air flow, nasal septal deviation\n* Blood samples for full genome sequencing",[87,88,89,90,91,92],"Diabetes Mellitus, Type 2","Obesity, Morbid","Obstructive Sleep Apnea","MODY","Diabetic Retinopathy","Diabetic Neuropathies","2024-02-15",{"date":95,"type":40},"2024-02-20",{"date":97,"type":40},"2022-07-15",{"date":99,"type":21},"2026-12-31",{"name":101,"class":47},"Steno Diabetes Center Greenland",1,""]